Publication date: Available online 24 October 2026 Source: Annals of Oncology Author(s): H.S. Rugo, M. Kok, A. Goncalves, D. Loirat, G. Bianchini, P.A. Fasching, D.W. Cescon, R. Romero Díaz, F. Zagouri, E. Korbenfeld, F. Dalenc, Y. Jerez Gilarranz, J. Hashimoto, Y.H. Park, S.-A. Im, X. Hu, K.M. Hirshfield, L. Jia, K. Tryfonidis, P. Schmid
Pembrolizumab Plus Chemotherapy for HR+/HER2− PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426080774?dgcid=rss_sd_all
Pembrolizumab Plus Chemotherapy for HR+/HER2− PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426080774?dgcid=rss_sd_all
“Pembrolizumab Plus Chemotherapy for HR+/HER2− PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study.” Annals of Oncology.
@article{article36276,
title = {Pembrolizumab Plus Chemotherapy for HR+/HER2− PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426080774?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...